_256_384.jpg)
Medical Device | November 25, 2024
Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
The recognition from Malaysia's NPRA, a member of PIC/S, opens doors to new global business opportunities
Our China operations continue under the leadership of the current General Manager of AstraZeneca China
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
The Notes shall not be offered or sold in India
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Subscribe To Our Newsletter & Stay Updated
